A 58-year-old male presents with severe alcohol use disorder…

A 58-year-old male presents with severe alcohol use disorder with 14 days of abstinence.  During his initial inpatient stabilization for alcohol withdrawal, he was diagnosed with liver impairment.  He reports significant struggle with cravings to use to his PMHNP.  Which medication does the PMHNP consider that increases GABA, is FDA approved to treat alcohol use disorder, is not metabolized by the liver, and has been shown to assist with less quantity and frequency of drinking as well as reduce risk of heavy drinking?

A 30-year-old patient presents for treatment of opioid use d…

A 30-year-old patient presents for treatment of opioid use disorder and methamphetamine disorder.  Baseline labs return showing that the patient is positive for hepatitis C.  What preventative recommendations for immunization will be prioritized by the PMHNP?